Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
THNR
18
HOLDINGS
39%
ALSO IN PJP
PJP
32
HOLDINGS
25%
ALSO IN THNR
SECTOR DRIFT (THNR minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 5.2% | 5.2% |
|
ABBVIE INC | 5.1% | 5.1% | 5.1% |
|
AMGEN INC | 5.5% | 5.1% | 5.1% |
|
PFIZER INC | 5.3% | 4.9% | 4.9% |
|
MERCK & CO. INC. | 5.1% | 4.8% | 4.8% |
THNR Overweight Relative to PJP
 |
NOVO-NORDISK A/S-SPONS ADR | 8.4% |
|
VIKING THERAPEUTICS, INC. | 5.5% |
 |
ASTRAZENECA PLC | 5.4% |
 |
CHINA PHARMACEUTICAL GROUP | 5.3% |
 |
INNOVENT BIOLOGICS, INC. | 5.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.9% |
|
ELI LILLY & CO | 4.9% |
|
ZEALAND PHARMA A/S | 4.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 4.0% |
 |
HANMI PHARM CO LTD | 3.6% |
THNR Underweight Relative to PJP
|
ABBOTT LABORATORIES | -5.2% |
|
JOHNSON & JOHNSON | -5.0% |
|
CORCEPT THERAPEUTICS INC | -3.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -3.6% |
|
TRAVERE THERAPEUTICS, INC. | -3.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | -3.4% |
|
LIGAND PHARMACEUTICALS-CL B | -3.3% |
|
OCULAR THERAPEUTIX INC | -3.2% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -3.2% |
|
TARSUS PHARMACEUTICALS, INC. | -2.9% |